Maastricht University Medical Center, Maastricht, the Netherlands
11-12 May, 2011
The aims of the Third BHD Symposium are to communicate advances in the understanding, management and treatment of Birt-Hogg-Dubé (BHD) syndrome and, for the first time, of hereditary leiomyomatosis and renal cell cancer (HLRCC), as well as to promote collaboration among researchers in these and related fields. Keynote talks, abstract presentations and a poster exhibition will cover basic and clinical research in BHD and HLRCC. Prizes for exceptional posters will be awarded. Additionally, there will be patient- and family-centered sessions. Abstracts can be submitted in the following categories:
1. Birt-Hogg-Dubé syndrome, basic sciences
2. Birt-Hogg-Dubé syndrome, clinical sciences
3. HLRCC, basic sciences
4. HLRCC, clinical sciences Further details available at The Third BHD Symposium site.
|
|
|
Invited Speakers:
|
|
Professor Bin Teh, Van Andel Institute, USA Dr Kuniaki Seyama, Juntendo University, Japan Dr Sunil Sudarshan, University of Texas Health Science Center at San Antonio, USA Professor Ian Tomlinson, Wellcome Trust Centre for Human Genetics, University of Oxford, UK Dr Patrick J Pollard, Centre for Cellular and Molecular Physiology, University of Oxford, UK
|
|